Imbio PHA (4.0.0) vs Rooti Rx ECG Event Recorder
AI Verdict
Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA (4.0.0) if your clinical workflow involves analyzing CT pulmonary angiogram (CTPA) scans for rapid, automated assessment of cardiac structures. This tool is ideal for radiologists and cardiologists needing to quickly identify potential right ventricular dilation and risk stratify patients with suspected pulmonary embolism or hypertension based on imaging data.
View Imbio PHA (4.0.0) →Choose Rooti Rx ECG Event Recorder if…
Choose Rooti Rx ECG Event Recorder if you require continuous, ambulatory cardiac monitoring for up to seven days to capture intermittent arrhythmias or assess long-term heart rhythm. This wearable device and its AI-powered platform are best suited for remote patient monitoring, enabling rapid diagnostic reports for patients experiencing symptoms outside of a clinical setting.
View Rooti Rx ECG Event Recorder →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio PHA (4.0.0) | Rooti Rx ECG Event Recorder |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). | Cloud-based (RootiCare platform on AWS) and device-based |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Imbio PHA (4.0.0)Imbio PHA seamlessly integrates into existing radiology PACS and DICOM workflows, automating image analysis and delivering results within minutes, which minimizes disruption for clinicians. While Rooti Rx offers patient comfort with its wearable, it requires a separate device and platform for data collection and review, making Imbio PHA's integration into established clinical workflows more advantageous for its target users.
Clinical Value
TieBoth tools offer significant and distinct clinical value, and both are FDA-cleared. Imbio PHA provides rapid, quantitative risk stratification for acute conditions like pulmonary embolism from existing CT scans. Rooti Rx offers continuous, long-term monitoring for intermittent cardiac events and sleep apnea, enabling earlier detection and diagnosis. Their contributions address different critical needs within cardiology, leading to a tie.
Pricing & Value
TieBoth Imbio PHA and Rooti Rx explicitly state 'contact for pricing' and do not provide public pricing details. Without transparent pricing information or publicly available case studies detailing their cost-effectiveness, it is impossible to definitively compare their pricing and value propositions.
Enterprise Readiness
Rooti Rx ECG Event RecorderWhile Imbio PHA offers flexible deployment (cloud/on-premise) and explicit third-party HIPAA and GDPR certifications, along with 24/7 support, Rooti Rx demonstrates a broader commitment to enterprise-grade security and quality management. Rooti Rx boasts comprehensive compliance with HIPAA, GDPR, and multiple ISO certifications (27001, 27701, 13485), and leverages AWS for its cloud infrastructure.
Innovation
Rooti Rx ECG Event RecorderBoth tools are innovative, but Rooti Rx introduces a more disruptive approach by combining a compact wearable device for continuous, multi-day ECG and actigraphy recording with AI-driven interpretation, enabling remote monitoring and detection of intermittent events, and also assessing sleep apnea. Imbio PHA innovates by applying AI to automate and standardize the analysis of existing CT images, which is an enhancement of existing workflows.
Support & Docs
Imbio PHA (4.0.0)Imbio PHA explicitly states 24/7/365 support via multiple channels (phone, email, online case submission) and provides access to user manuals upon request. Rooti Rx offers an instruction manual and FAQs, along with contact information, but does not explicitly detail 24/7 support availability. Imbio PHA's clearly defined and comprehensive support structure gives it an advantage.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio PHA (4.0.0) | Rooti Rx ECG Event Recorder |
|---|---|---|
| Product Name | Imbio PHA (4.0.0) | Rooti Rx ECG Event Recorder |
| Company | Imbio | Rooti Labs Ltd. |
| Description Summary | AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. | Compact, wearable ECG event recorder that, combined with the AI-powered RootiCare platform, provides continuous cardiac monitoring and rapid, accurate diagnostic reports for medical professionals. |
| Core Technology/Modality | AI-powered medical image processing (CTPA scans) | Wearable ECG device with AI-driven interpretation |
| Key Measurements/Outputs | Automated measurement of right and left ventricle diameters, main pulmonary artery and aorta diameters; calculates RV/LV and PA/Ao ratios; generates annotated DICOM images and PDF summary reports. | Up to 7-day ECG and actigraphy recording; 24-bit high-resolution ECG images; online ECG review and editing; fast report generation within 24 hours. |
| Target Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Family Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and Rooti Rx ECG Event Recorder.